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ABSTRACT Atomistic simulations of nitric oxide (NO) dynamics and migration in the trHbN ofMycobacterium tuberculosis are
reported. From extensive molecular dynamics simulations (48 ns in total), the structural and energetic properties of the ligand
docking sites in the protein have been characterized and a connectivity network between the ligand docking sites has been built.
Several novel migration and exit pathways are found and are analyzed in detail. The interplay between a hydrogen-bonding
network involving residues Tyr33 and Gln58 and the bound O2 ligand is discussed and the role of Phe
62 residue in ligand migration
is examined. It is found that Phe62 is directly involved in controlling ligand migration. This is reminiscent of His64 in myoglobin,
which also plays a central role in CO migration pathways. Finally, infrared spectra of the NO molecule in different ligand docking
sites of the protein are calculated. The pocket-speciﬁc spectra are typically blue-shifted by 5–10 cm1, which should be detect-
able in future spectroscopic experiments.INTRODUCTION
In recent years, the microbial hemoglobins (Hbs) have
received much attention due to their wide range of functions
in microorganisms (1,2). Three groups of Hbs have been
identified in microorganisms, namely, flavohemoglobins
(FHbs), single domain Hbs, and truncated Hbs (trHbs) (3).
The FHbs contain a globin domain with a classical three-
over-three a-helical structure and an additional flavin-con-
taining reductase domain covalently attached to it. While
the single domain Hbs share high sequence and structure
homology with the globin domain of the FHbs, the trHbs,
on the other hand, are much smaller with z110–140
amino-acid residues and exhibit a two-over-two a-helical
structure (3–10).
The trHbs are phylogenetically divided into three
groups—group I (trHbN); group II (trHbO); and group III
(trHbP) (3)—which are 20–40 amino-acids shorter than the
mammalian Hbs due to the presence of several shortened
a-helices in trHbs. However, the residue deletions, inser-
tions, and replacements relative to the vertebrate globin
sequences are distributed throughout the globin chain. The
trHbs host the heme in a two-over-two a-helical sandwich
based on four helices, corresponding to the B, E, G, and H
helices of the classical globin fold. The B/E and G/H helix
pairs run antiparallel and surround the heme group to keep
the latter safe from solvents. As compared to the classic
globin fold, the trHbs show a drastically shortened A helix
(absent in some cases, e.g., group III trHb). The D helix of
classic globin fold is usually absent and the proximal F helix
is almost completely replaced by an extended pre-F helix.
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0006-3495/09/03/2105/14 $2.00The stabilization in the shortened helices to build a properly
structured heme crevice is provided by three glycine-based
motifs in group I and II trHbs (7).
Pesce et al. (10) and Milani et al. (11,12) have analyzed
the crystal structures of several group I trHbs, including
the crystal structure of group I trHb ofMycobacterium tuber-
culosis, which is the primary focus of this work. One in every
three human beings in today’s population is latently infected
by M. tuberculosis (13,14), the causative agent of tubercu-
losis. It is now widely believed that the microorganism over-
comes the toxicity of nitric oxide (NO) by converting it to
harmless nitrates (15,16).
The trHbN ofM. tuberculosis has a dimeric assembly. The
dimer has an elongated shape, positioning the two hemes
22 A˚ apart. The interface area between two trHbN chains
is ~310 A˚2 (11). The crystal structure reveals the presence
of an almost continuous tunnel through the protein matrix
connecting the heme distal pocket to the protein surface at
two distinct sites (11). The tunnel is composed of two
orthogonal branches, stretching 20 A˚ and 8 A˚ from the
respective access sites to the heme ligand site, and has
a diameter of 5–7 A˚, thus covering a volume of z330–
360 A˚3 (11). The crystal structure of trHbN with Xe
atoms under pressure shows eight Xe atoms with different
occupancy levels, three of which fall in the shorter
branch of the tunnel and two in the longer branch of the
tunnel (12).
There have been a number of experimental studies devoted
to the spectroscopic aspects of several diatomic ligands (CO,
O2, NO, and CN) binding to the trHbN in M. tuberculosis
(15,17–20). These authors have studied several mutants of
the wt-trHbN and have proposed that the ligand binding is
largely controlled by a pair of interacting amino acids
(Gln58 and Tyr33) in the heme active site by participating
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addition to the spectroscopic investigations, there exist
several kinetic studies on ligand binding to trHbN (9). In
trHbN, the O2 binding is faster by a factor of two compared
to sperm whale Mb whereas O2 dissociation is two-orders-
of-magnitude slower in trHbN, due to the presence of a tun-
nel in the trHbN for a faster ligand diffusion to the heme
active site and the presence of ligand stabilizing
residue Tyr33 (15). It has also been shown that the ligand
binding is much faster in group I trHbs compared to the
group II trHbs, which lack a tunnel for ligand diffusion (5).
Nitric oxide has been found to play a pivotal role in
various physiological processes such as neurotransmission,
regulation of vasodilation, inhibition of mitochondrial respi-
ration, and immune response to bacterial infection (21,22).
Overproduction of NO is potentially toxic (23). Important
biological functions of NO involve its interaction with metal
centers of heme and other metal-containing proteins (24).
Additionally, nitric oxide is also known to participate in
the reaction with superoxide to form peroxynitrite, the
moiety that triggers several reactions such as lipid peroxida-
tion, DNA damage, or thiol oxidization (25). For heme
proteins, NO is a special ligand as it binds to both ferrous
and ferric iron on the picosecond timescale in a variety of
proteins including nitric oxide synthetase, guanylate cyclase,
hemoglobin, and myoglobin (24,26).
From crystallographic studies, it is proposed that residue
Phe62 exists in two conformations. In one, the benzene
side chain of the residue blocks the longer channel of the
tunnel path (the so-called closed state) and in the other it
does not (the open state) (11,12). By long MD simulations
(0.1 ms), Bidon-Chanal et al. have proposed that in deoxy-
trHbN, the Phe62 adopts the closed conformation and hence
the O2 ligand enters the protein via the short channel. In case
of oxygenated trHbN, the Phe62 prefers the open conforma-
tion, thus facilitating the entrance of the second ligand (NO)
via the long channel (27,28).
The active sites of heme proteins are often buried inside
the globin chain, which prevents direct contact with solvent.
Therefore, the ligand has to trace its way to the heme by
traversing through the globin chain. The driving force under-
lying the ligand migration is commonly believed to be due to
thermal fluctuations of the proteins (29). The migration path-
ways and ligand access sites are located in, most likely,
evolutionarily optimized well-defined regions of proteins
that can be identified with systematic experimental and
computational efforts (30). With the development of time-
dependent crystallographic methods, it is now possible to
investigate the time evolution of the ligand distribution after
flash photolysis of heme-bound ligand (31–34). While such
experimental methods are yet to be used routinely, computer
simulations have complemented our understanding of ligand
migration pathways, for example, in myoglobins by the so-
called ligand implicit sampling method (35). In ligand
implicit sampling, locating ligand migration pathways is
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simulations of the dynamical fluctuations of the protein in
the absence of a ligand. The method provides complete
three-dimensional maps of the potential of mean force for
ligand placement anywhere in the protein. By using this
method, several novel possible exit pathways have been sug-
gested for myoglobin (35). The idea underlying potential of
mean force-based implicit ligand sampling is the fact that
diatomic ligands, often approximated as apolar, only interact
weakly with the protein, and hence their impact on confor-
mational changes of the protein are approximated as a small
perturbation or even neglected. This approximation is,
however, vulnerable when the ligand is either charged or
possesses significant higher multipole moments, as is the
case for CN or NO. In such cases, an explicit ligand
sampling of the protein is required.
It is well known that NO can rapidly diffuse through the
protein matrix (36), can easily cross membranes (37), and
has a small barrier to escape to the bulk solvent (38). Hence,
it can be used as a probe to explore the interior of proteins,
such as active site conformations, ligand docking sites, or
solvent-accessible regions. Moreover, since the molecule
has an appreciable dipole moment, the NO stretching
frequency can also be used as a spectroscopic probe. Unfor-
tunately, because of its weak absorption cross section and
spectral overlap with the amide bands (when it is bound to
ferrous heme), measuring the NO stretching vibration has
always remained a challenging experimental problem (39–
42). Under such circumstances, computational investigations
of NO in the protein environment are of considerable interest
(26,43).
In this work, we use the NO ligand as a structural and
spectroscopic probe for the trHbN of M. tuberculosis and
employ the recently developed three-point fluctuating
charge model for NO (43) and a suitable Morse potential
for the N-O bond. The three-point fluctuating charge model,
obtained by fitting to high-level ab initio dipole and
quadruple moments, provides an accurate description of
the electrostatic interactions between the ligand and the
protein environment by correctly describing the variation
of the multipole moments of the ligand as a function of its
bond length (43).
COMPUTATIONAL METHODS
The initial structure of the protein is the x-ray crystal structure (Protein Data
Bank entry 1IDR) and only monomer A of this homodimeric protein is
considered in this study. Hydrogen atoms are added and the internal coordi-
nates are built by using the appropriate modules of the CHARMM program
(44). The protein contains 131 amino-acid residues, a prosthetic heme group
as well as O2 and NO ligands. All histidine residues are treated as d-proton-
ated. The heme group is covalently bound to the N of residue His81 and the
dioxygen molecule is ligated to the FeII atom of the heme group, while the
NO ligand remains unbound. A water box with dimension 62.1  52.8 
68.3 A˚3 is used to solvate the protein. The water molecules are represented
via the modified TIP3P potentials (45). The water box was heated and equil-
ibrated for 50 ps at 300 K before the protein was solvated. After deleting the
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water molecules and the entire system has 21,975 atoms.
All MD simulations are carried out with the CHARMM22 force field (46)
and the CHARMM program (44). Nonbonded interactions are truncated at
a distance of 14 A˚ by using a shift function for the electrostatic terms and
a switch algorithm for the van der Waals terms (47). All bonds involving
hydrogen atoms are kept fixed by using SHAKE (48). The systemwas slowly
heated to 300 K and equilibrated for at least 300 ps before free dynamics is
performed at a constant temperature of 300K.Wehave considered six starting
structures of the protein by taking snapshots when the NO ligand is in one of
the Xe1–Xe5 pockets and in the proximal docking site (PDS) (see Fig. 1 for
the locations of the NO ligand in these six snapshots, represented by spheres).
Four trajectories of 2-ns duration eachwere initiated fromeach of the six snap-
shots, which gives 24 trajectories each of 2-ns time length.
The recently developed three-point fluctuating charge model (43) for the
dissociated NO molecule is used to describe the electrostatics of NO. All
other interactions are treated with the CHARMM22 force field (46). The
three-point fluctuating charge model is an improvement over the atom
FIGURE 1 Ribbon representation of trHbN showing the structural
elements. The heme group is shown with sticks and the ligand docking sites
are shown by spheres. The docking sites are labeled according to the corre-
sponding Xe pocket indices. The sphere-labeled PDS indicates the ligand
docking site in the proximal side of the heme group, which is not seen in
the crystallographic study of Milani et al. (11). The Phe62 residue, which
acts as a gate for ligand migration from Xe5 pocket to Xe1 pocket, is shown
with black sticks.centered point-charge model in the sense that the latter are the 0th order
expansion terms of the electrostatic potentials of the electron-density distri-
bution. The expansion converges by considering the higher order expansion
terms, which are essentially the higher order multipole moments of the
ligand molecule. The charge model employed in this work is accurate up
to the NO-quadrupole moment and thereby has the additional advantage
of providing a more realistic description of the electrostatic interactions
between the ligand and the protein environment. While the van der Waals
parameters for the NO ligand are taken from Meuwly et al. (49), the
N-O bond is described by a Morse potential,
VM ¼ De½1 expð  bðr  reÞÞ2; (1)
with dissociation energy De ¼ 152.6 kcal/mol, b ¼ 2.636 A˚1, and equilib-
rium bond distance re ¼ 1.151 A˚ (50). All force field parameters for the
NO molecule are given in Table 1.
The free-energy profile along a progression coordinate (q) is estimated
from the probability distribution P(q) via the relation
DGðqÞ ¼ kBT In PðqÞ; (2)
where kB is the Boltzmann constant (1.9875 103 kcal/mol/K) and T is the
temperature in Kelvin.
The infrared absorption spectrum of the NO molecule is calculated by
using the relation
AðuÞ ¼ u

1 exp

 Zu
kBT

CðuÞ; (3)
where C(u) is the Fourier transform of the dipole-dipole autocorrelation
function,
CðtÞ ¼ h~mð0Þ~mðtÞih~mð0Þ~mð0Þi; (4)
obtained from the dipole moment time series of the NO molecule accumu-
lated from a given trajectory. For further details on the calculation of infrared
spectra, see Nutt and Meuwly (51).
RESULTS
Characterization of the ligand docking sites
The crystal structure of trHbN exhibits a continuous tunnel
through the protein matrix with two perpendicularly placed
channels. One end of each of the channels opens to the
solvent while the other toward the heme. The entrance of
the longer channel (channel I) is defined by residues Ile19,
Ile25, Val28, and Leu102 whereas the entrance of the shorter
channel (channel II) is surrounded by residues Phe91,
TABLE 1 Force-ﬁeld parameters for NO molecule
VNO ¼ De(1  exp(b(r  r0)))2
De ¼ 152.6 kcal/mol,
b ¼ 2.636 A˚1, r0 ¼ 1.151 A˚
qN ¼ a0 þ a1r þ a2r2 þ a3r3 a0 ¼ 6.3 e, a1 ¼ 11.5 eA˚1,
a2 ¼ 7.3 eA˚2, a3 ¼ 1.6 eA˚3
qO ¼ a0 þ a1r þ a2r2 þ a3r3 a0 ¼ 10.7 e, a1 ¼ 19.0 eA˚1,
a2 ¼ 11.4 eA˚2, a3 ¼ 2.4 eA˚3
qCoM ¼ qN þ qO
Nonbonded parameters (N) 3N ¼ 0.20 kcal/mol, rN ¼ 2.00 A˚
Nonbonded parameters (O) 3O ¼ 0.16 kcal/mol, rO ¼ 2.05 A˚
The Morse potential, the atomic (fluctuating) charges, and the nonbonded
parameters (the van der Waals well depth 3 and radii r) are taken from the
literature (43,49,50), respectively.
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tunnel entrances and their inner surface are apolar. From
Xe-pressurized protein samples three docking sites along
channel II (the Xe2, Xe3, and Xe4 pockets) and two docking
sites along channel I (the Xe1 and Xe5 pockets) were found
FIGURE 2 Contour plots in the xy-,xz-, and yzplanes showing theprobability
distribution of the NO ligand from all the simulations. The heme plane is along
the xy plane and the origin is shifted to the center of mass of the four N atoms of
the porphyrin ring of the hemegroup. The ligand situated in differentXe pockets
are labeled. The population of Xe4 pocket is too low to appear in the figure.
Biophysical Journal 96(6) 2105–2118(12). In addition to these five Xe pockets, these simulations
reveal the presence of an additional stable docking site
(called proximal docking site: PDS) situated in the proximal
side of the heme group in trHbN. A schematic diagram
showing the Xe pockets and the PDS site in the trHbN is
given in Fig. 1.
The cumulative probability distribution of the NO mole-
cule in the three Cartesian planes from all 24 trajectories is
shown in Fig. 2. The average heme plane is in the xy plane
and the origin is at the center of mass of the four N atoms
of the porphyrin ring of the heme group. In the two-dimen-
sional projection of the ligand density distribution, some of
the ligand docking sites overlap. In the xy plane, the Xe2
pocket (due to its proximity to the heme group) and the
Xe3 pocket can be distinguished from other pockets.
However, a distinction between the Xe1 and Xe5 pockets
is difficult in the xy plane. In the xz plane, however, the
Xe1 and Xe5 pockets can be differentiated. The spatial prox-
imity of the Xe2 and the Xe1 pocket is best seen in the yz
plane (Fig. 2).
For a spatial description of the probability distribution of
the NO ligand from all simulations, Fig. 3 shows a three-
dimensional probability density of the NO ligand in trHbN
shown in its crystal structure conformation. While the
density of the ligand is shown by mesh, the heme group,
the bound O2, the proximal His
81, and the Phe62 residues
are shown by sticks. In the three-dimensional projection,
the ligand docking sites as well as their relative positions
FIGURE 3 Three-dimensional view of the probability distribution of the
NO ligand during the entire period of simulation. The heme group, proximal
His81, bound O2, and Phe
62 are shown and the ligand docking sites are indi-
cated. The population of Xe4 pocket is too low to appear in the figure. The
figure is prepared using Surfplot software (67).
NO Migration in Truncated Hemoglobin 2109FIGURE 4 Time evolution of the x-, y-, and z coordi-
nates (from top to bottom at time t ¼ 0) of the position
vector of N atom of the NO ligand, with respect to the
center-of-mass of the four N atoms of the porphyrin ring
of the heme group, in four trajectories chosen to illustrate
ligand migration. The trajectories shown in panels a–d
are started from snapshots with the NO ligand in the
Xe1, Xe2, Xe3, and Xe5 pockets, respectively. The loca-
tions of the NO ligand during the simulations are marked
in each of the figures. The intermediate site in between G
and H helices is indicated by IS1 and the asterisk refers
the ligand at the entrance of channel I.and the degree of overlap with each other are discernible.
In the distal side of the heme group, nearest to the bound
O2 ligand is the Xe2 pocket. The Xe5 and Xe1 pockets
show overlapping density, which reflects the continuity of
channel I. The Phe62 residue is situated between these two
pockets. The region of the Xe1 pocket most distant from
the heme plane corresponds to the entrance of channel I.
The Xe4 pocket has negligible ligand density in these simu-
lations, since the ligand upon arrival at the Xe4 pocket
rapidly diffuses to bulk solvent via the opening of channel
II. The Xe3 pocket is spatially close to the Xe2 and Xe5
pockets. The ligand docking site in the proximal side of
the heme group and close to the His81 ring is the proximal
pocket, which is not seen in crystallographic studies
(11,12) and earlier simulations.
Fig. 4 shows the time evolution of the x-, y-, and z coordi-
nates of the N atom of the NO molecule in four representa-
tive trajectories. For this purpose, the entire protein was
reoriented so that the least-squares plane containing the four
nitrogen atoms of the heme group lies in the xy plane, with
the center-of-mass of the four nitrogen atoms placed at the
origin. In the trajectory shown in Fig. 4 a, the NO ligand
is initially in the Xe1 pocket. The ligand is found to move
very rapidly from the Xe1 pocket to the Xe5 pocket and
remains there briefly (for <10 ps) before returning to the
Xe1 pocket. This process is completed within the first
50 ps of the simulation. Afterwards, the NO ligand remains
in the Xe1 pocket for ~1 ns, then proceeds toward the Xe3
pocket via an intermediate site (IS1) between helices G
and H (see Fig. 4 b). At ~1800 ps, the ligand migrates to
the Xe4 pocket and further moves along channel II. In the
trajectory shown in Fig. 4 b, the NO ligand starts in the
Xe2 pocket. The ligand remains in the Xe2 pocket for
~500 ps and then proceeds to the Xe1 pocket. After this,
rapid transitions between Xe1 and Xe3 pockets occur.Finally, via the intermediate site between helices G and H
(IS1), the ligand moves to the Xe4 pocket and from there
it escapes to the bulk water. In the example trajectory shown
in Fig. 4 c, the ligand starts from the Xe3 pocket and rapidly
moves toward the Xe2 pocket (along channel II). The ligand
is then found to make several transitions between the Xe2
and Xe1 pockets. During the last 400 ps of the simulation,
the ligand remains in IS1. In the last trajectory (Fig. 4 d)
the ligand is initially in the Xe5 pocket and the ligand move-
ment in this trajectory is primarily restricted to channel I
(i.e., Xe5 and Xe1 pockets; see Fig. 4 d). In several of the
calculated trajectories (i.e., 14 out of 24), the ligand escapes
to the bulk solvent in <2 ns.
The primary ligand docking sites, their distance from the
Fe atom of heme, the residues surrounding the docking sites,
and the connectivity of the docking sites with other docking
sites are given in Table 2.
The Xe1 pocket connects the Xe5 pocket with the entrance
of channel I. Starting from the Xe1 pocket, the ligand
migrates along three primary pathways: 1), to the Xe5
pocket; 2), toward the opening of channel I; or 3), toward
the Xe3 pocket. The transfer of the ligand from the Xe1
pocket to the Xe5 pocket is assisted by the rotation of the
phenyl ring of Phe62 residue. From Xe1 to Xe3, the ligand
moves via the intermediate site (IS1) in between the helices
G and H of trHbN. This intermediate site is surrounded by
Ala95, Leu98, Ala99, Ile112, Ile115, and Leu116 amino acids.
The NO ligand is found to traverse this region of the protein,
which connects the Xe1 pocket in channel I with the Xe3 and
Xe4 pockets in channel II, in several trajectories.
Xe2 pocket is the closest docking site in the distal side of the
heme group and hence is crucial for ligand rebinding and
ligand chemistry such as oxidation of NO. Xe2 pocket is the
intersection of channels I and II. Starting from theXe2 pocket,
the ligand can either move along channel II to the Xe3 pocket
Biophysical Journal 96(6) 2105–2118
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Pocket Distance (A˚) Surrounding residues Connectivity
Xe1 13 Phe62, Ile25, Ile115, Val28, Val29, Leu98 IS1, Xe5, Xe2, Xe3
Xe2 6 Phe32, Leu98, Ala94, Phe62, Tyr33, Gln58 Xe5, Xe3, Xe1, Solvent
Xe3 12 Phe62, Leu98, Leu66, Ile115 Ile119, Val118, Ala65 Xe1, Xe2, Xe4, IS1, Solvent
Xe4 15 Met88, Phe91, Ser92, Ala95, Gly96, Ala123 Xe3, IS1, Solvent
Xe5 9 Phe62, Ala65, Leu66, Leu98, Ile115, Val118 Xe1, Xe1, Solvent
PDS 6 Ile119, Phe91, His81, Val124, Ala123, Asp125, Val126, Met77 Xe2
The averaged distance of N atom of NO to Fe when NO is in a particular docking site of the protein is given in A˚.or along channel I to the Xe5 pocket. In addition, we also
observed less frequent transitions from the Xe2 pocket to
the Xe1 pocket. In some cases, the ligand from the stable
Xe2 pocket was also found to move toward the C helix and
escape to the bulk water via an exit pathway situated between
helices C and F, and surrounded by Phe46, Thr49, Met51, and
Leu54 residues. The ligand remains in the Xe2 pocket for a
longer period of time as compared to the other docking sites
of the protein. This supports the proposal for multiligand
chemistry taking place in the active site of the protein (16,52).
The Xe3 pocket, situated in the midway of channel II, has
close access to bulk water and connects pockets Xe2 and
Xe4. The ligand from the Xe3 pocket can move toward the
Xe2 and Xe4 pockets along channel II or can move toward
IS1 before reaching Xe1. In some cases, the ligand is found
to move directly from the Xe3 pocket to the Xe1 pocket.
Since the ligand spends typically a few tens of picoseconds
in Xe3 pocket, this site is considered to be metastable.
This is in agreement with the crystallographic observation
that the Xe3 pocket is not a well-defined pocket in the A
monomer of the trHbN dimer (12).
Starting from the Xe4 pocket, the ligand either moves
along channel II toward the Xe3 pocket or escapes to the
solvent. In addition to the movement along channel II, the
ligand from Xe4 pocket is also seen to move toward IS1.
The Xe5 pocket is found in between the Xe1 and Xe2
pockets along channel I. From the Xe5 pocket, the ligand
travels along channel I either toward the Xe1 pocket or
toward the Xe2 pocket. Additionally, the ligand from the
Xe5 pocket is also found to proceed to the bulk water via
a region between the helices E and F, surrounded by Pro71,
Tyr72, Phe62, Ala65, and Pro121 residues.
The PDS is extremely stable and the ligand exhibits no
migration from this pocket during our 8 ns of simulation of
the protein with NO in this pocket. The ligand in this docking
site is surrounded by hydrophobic residues and has very little
probability to escape the docking site.
Summarizing all ligand migration pathways from the
simulations leads to a connectivity diagram for NO ligand
transfer in trHbN, which is shown in Fig. 5. Although the
apolar channels are the most preferred pathways for the
ligand migration, the NO ligand does follow pathways in
addition to the two channels, e.g., the transitions between
Xe3/Xe2 and Xe1, and transitions between Xe4/Xe3 and
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via which the ligand can migrate through the protein to the
bulk water. Two of these pathways are the openings of chan-
nels I and II, and the other two are the exit channels outside
the tunnel of the protein (in between helices E and F and
helices C and F).
Fig. 6 shows the free energy profile for the migration of
the NO ligand in the trHbN protein matrix, estimated from
the probability density of the Fe-N distance averaged over
all the calculated trajectories as described in the previous
section. The energy profile exhibits two distinct minima
separated by a barrier of 1.2 kcal/mol. While the minimum
at the lower value of Fe-N distance (~5 A˚) corresponds to
the Xe2 pocket and the proximal docking site of the protein,
the broad minimum at the higher Fe-N distance corresponds
to the Xe1, Xe3, and Xe5 pockets. These three pockets
are indistinguishable in the free-energy profile along the
Fe-N distance due to frequent transitions among these
pockets that lead to a wide local minimum associated with
the corresponding pockets, making an energetic distinction
of these pockets along the Fe-N coordinate difficult. An ener-
getically distinct characterization of individual docking sites
can be achieved by nonequilibrium sampling methods such
as umbrella sampling along some progression coordinates
that can effectively distinguish the ligand docking sites.
FIGURE 5 Connectivity network between the NO ligand docking sites
within the trHbN protein matrix. The observed ligand transitions among
various protein pockets are indicated by arrows. The loss of ligand to the
bulk solvent is indicated by arrows toward water.
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58, and Tyr33
The experimental spectroscopic and kinetic studies suggest
the presence of an H-bonding network involving Tyr33,
Gln58, and bound O2 in the heme active site (15,17,18).
Computational studies have been carried out to further char-
acterize the H-bonding network in the heme active site for
deoxy- and oxy-trHbN (28). In the following, we corroborate
the experimental findings regarding the H-bonding network
between the bound O2 ligand and Tyr
33 and Gln58 residues
by analyzing the time evolution of their interactions and
provide energetic estimates for these H-bonds. Fig. 7 illus-
trates the H-bonding pattern from a typical MD simulation
and shows the time series of the distance between 1), the
O2 atom (of O2) and the phenolic O of the Tyr
33; 2), the
amide N of the Gln58 and the phenolic O of the Tyr33; 3),
the phenolic O of the Tyr33 and the amide O of the Gln58;
and 4), the O2 of the bound O2 and the amide N of the
Gln58, are given for such an example trajectory. Initially,
H-bonds between the O2 and the phenolic O of the Tyr33,
and the phenolic O of the Tyr33 and the amide N of the
Gln58, are present (see Fig. 7 a). This situation is graphically
illustrated in Fig. 8 a(I). After 60 ps, the phenolic O of the
Tyr33 approaches the carbonyl O of the Gln58 (see the
reduced bond distance in Fig. 7 c), leading to the breaking
of the H-bond between the Tyr33 and the O2 atom and the
formation of the H-bond between the amide O of the Gln58
and the phenolic O of the Tyr33 (shown in Fig. 8 a(II)). After
z500 ps, the Tyr33 separates further from the O2 ligand,
while the amide group of Gln58 moves closer with the possi-
bility to form an H-bond between the amide N of Gln58 and
O2 of the bound O2 (Fig. 7 c).
The free-energy profiles, associated with the H-bonded
network calculated from all 24 trajectories, are shown in
FIGURE 6 Free-energy profile for the migration of the NO ligand in the
trHbN protein matrix. The progression coordinate is the distance between
Fe atom of the heme and N atom of the NO ligand. The minimum at smaller
Fe-N distance corresponds to the Xe2 pocket and the PDS, while the broad
minimum at larger Fe-N separation corresponds to the Xe1, Xe3, and Xe5
pockets.Fig. 8 b. It is seen that Tyr33 exhibits two conformations
with respect to the bound O2 ligand, regulating the H-bond
between the phenolic O of Tyr33 and O2. The energy barrier
between the H-bonded Tyr33-O2 pair to the free Tyr
33 and O2
ligand is z1 kcal/mol. In contrast, the energy barrier to
break the H-bonding between the phenolic O of the Tyr33
and carbonyl O of the Gln58 is z2 kcal/mol (see Fig. 8 b).
As shown in Fig. 8 a, the amide group of Gln58 and the
phenol ring of Tyr33 are found in three different conforma-
tions that also differ in their relative orientation. The
minimum found at 3 A˚ corresponds to the situation where
the amide O of Gln58 acts as an H-bond acceptor of the
phenolic H of Tyr33 and the phenolic O of Tyr33 acts as an
H-bond acceptor of the amide H of Gln58 (Fig. 8 a(II)).
The intermediate minimum at 4.8 A˚ corresponds to the
situation shown in Fig. 8 a(I), in which Tyr33 participates
in H-bonding to the bound O2 ligand as well as with the
amide group of Gln58. The conformation with the distance
between the N atom of Gln58 and the O atom of Tyr33 at
6.5 A˚ reflects the situation where the amide group of Gln58
is engaged in H-bonding with O2 of the O2 ligand and
Tyr33 participates in the H-bonding with the amide O of
Gln58 (Fig. 8 a(III)).
Phe62 controlled ligand migration along channel I
We have analyzed the trajectories calculated in this work to
discuss the opening and closing of the Phe62 gate and its
effects on the ligand migration. Similar to previous studies
(11,12,27,28), we find the Phe62 residue exhibiting two
conformations. In one of the conformations, the phenyl
ring of the residue blocks the channel I while in the other
it lets the ligand move along channel I. Our simulations
revealed that the Phe62 residue in the oxy-trHbN exhibits
FIGURE 7 Time series of distances between (a) O2 of the bound O2 and
the phenolic O of the Tyr33; (b) the phenolic O of the Tyr33 and the amide
N of the Gln58; (c) the phenolic O of the Tyr33 and the amide O of the Gln58;
and (d) O2 of the bound O2 and the amide N of the Gln
58, for an example
trajectory illustrating H-bonding pattern among Tyr33, Gln58, and the bound
O2 molecule.
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of Tyr33, Gln
58, and the bound O2 molecule during the
trajectory shown in Fig. 7. (b) Free-energy profiles for
H-bonding among Gln58, Tyr33, and the bound O2 mole-
cule. (Inset) Progression coordinates associated with the
energy curves.primarily the open conformation (probability >70%), see
Fig. 9 a, where the averaged probability distribution of the
dihedral angle Ha-Ca-Cb-Cg of Phe
62 residue provides
a comparison between the populations of the closed and
open conformations. By analyzing individual trajectories,
we found that the change in conformation is a less frequent
event. The conformational change from an open state to
a closed state is more rare than the opposite, indicating the
presence of a larger energy barrier for an open-to-closed tran-
sition. This is verified from the free energy profile calculated
for the ring torsion of the Phe62 residue. For the oxy-trHbN,
the open state conformer is found 1.5 kcal/mol more stable
than the closed conformer. The energy barrier for closed-
to-open transition is ~1.2 kcal/mol whereas the reverse
energy barrier is >3 kcal/mol (see Fig. 9 b). The barrier
for ring torsion originates from a combination of 1), H-
bond breaking and formation between Tyr33 and Gln58
residue pair; and 2), steric interactions between Phe62 and
Gln58 residues.
To illustrate the ligand migration associated with the
open-closed transition of the Phe62 residue, we present an
Biophysical Journal 96(6) 2105–2118example trajectory in Fig. 9, c and d, where the ligand move-
ment and Phe62 ring torsion are visibly correlated. The time
series of the dihedral angle Ha-Ca-Cb-Cg of Phe
62 is plotted
in Fig. 9 c and the time series of the x-, y-, and z coordinates
of the NO ligand in the trajectory is plotted in Fig. 9 d. (The
ligand transition between the Xe5 and the Xe1 pockets is
indicated by the vertical dashed lines in Fig. 9, c and d.)
During this simulation, the phenyl ring adopts both closed
and open conformations and during the first nanosecond of
the simulation, three transitions occur between the two
conformations. The ligand is initially found in the Xe5
pocket, where it stays for ~240 ps before it moves along
channel I toward the Xe1 pocket. During the transition of
the ligand from the Xe5 pocket to the Xe1 pocket, the
Phe62 residue exhibits open conformation and soon after
the transition, the residue adopts the closed conformation
(see Fig. 9 c at 300 ps). The ligand remains in the Xe1 pocket
for next 250 ps, during which the Phe62 remains in the closed
conformation. At ~475 ps, Phe62 adopts the open conforma-
tion and 5 ps later, the ligand moves along the open channel
toward Xe5 pocket. This example trajectory clearly
NO Migration in Truncated Hemoglobin 2113demonstrates the ligand migration being controlled by the
change in the Phe62 conformation.
Infrared spectra of NO in trHbN
The harmonic (ue) and the fundamental (ne) frequency asso-
ciated with a Morse potential (Eq. 1) are given by
ue ¼ Zb
ﬃﬃﬃﬃﬃﬃﬃﬃ
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s
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With the Morse potential used in this work, the analytic
fundamental and harmonic frequencies of NO are (ne)
1798.8 cm1 and (ue) 1830.1 cm
1, respectively. To
investigate the performance of the Morse potential used for
N-O bond in the MD simulations, we calculated the infrared
spectrum of an isolated NO molecule in vacuum. The result-
ing spectrum shows a sharp peak at 1837.5 cm1. The differ-
ence of 39 cm1 compared to the calculated fundamental
frequency (ne) is consistent with the previous investigations
for similar systems (51,53) and is related to two factors: 1),
the classical treatment of the Morse potential; and 2), the
use of Verlet integrator with the time step of 1 fs employed
to integrate the equations of motion in the MD simulations
(51,53). The experimental gas phase infrared spectrum of
NO shows absorption at 1875.9 cm1 (50). In myoglobin,
the infrared spectrum of photodissociated NO exhibits two
peaks at 1857 and 1867 cm1 and spreads over a spectral
window of 10–30 cm1 between 1840 and 1880 cm1
(39,42).
The infrared spectrum of NO in the protein environment
averaged over all 24 individual trajectories is broad with
extended tails to both sides of the central, most intense
feature, and exhibits several peaks as shown in Fig. 10 a.
It spans over a spectral region of 20 cm1 between 1830
and 1850 cm1, centered around the gas phase NO absorp-
tion peak at 1837.5 cm1 (see dashed line in Fig. 10 a).
The averaged infrared spectrum shows an intense peak at
1837.5 cm1 with a shoulder at 1839 cm1. Two additional
peaks with moderate-to-high intensity are seen to the red (at
1835.5 cm1) and blue (at 1840.5 cm1) side of the central
peak. The position, relative intensity, and width of six
Gaussian functions fitted to the spectral features of
Fig. 10 a are given in Table 3.
Fig. 10 b shows NO-infrared spectra from four trajecto-
ries, which differ in the ligand sampling particular regions
FIGURE 9 (a) Average probability distribution of the
conformations of the dihedral angle Ha-Ca-Cb-Cg of
Phe62 residue in oxy-trHbN. (b) Free-energy profile associ-
ated with the ring torsion of the Phe62 residue. The dihedral
angle of 50 and þ50 corresponds to the open and
closed states of the Phe62 residue, which refer to the situa-
tions when the phenyl ring of Phe62 residue blocks and
unblocks, respectively, the passage between the Xe5 and
Xe1 pockets along channel I. Time series of (c) Phe62
phenyl ring torsion and (d) x-, y-, and z coordinates of
the NO ligand in an example trajectory to illustrate the
correlation between the movement of Phe62 and ligand
migration. The vertical dashed lines at 240 ps and 480 ps
indicate the migration of the ligand from the Xe5 to the
Xe1 pocket and the reverse migration, respectively.
FIGURE 10 (a) Infrared spectrum of NO ligand averaged over 24 spectra
calculated from individual trajectories. (b) NO infrared spectra from four
trajectories, which differ in the regions of protein sampled by the ligand.
(c) Averaged infrared spectra of NO in the Xe1 (black), Xe2 (red),
Xe5 (green), and the proximal pocket (blue). The absorption of NO mole-
cule in the gas phase is indicated by the dashed line at 1837.5 cm1.
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calculated from a trajectory where NO primarily remains in
the Xe1 and Xe5 pockets, with occasional migration to
Xe3. The red spectrum corresponds to a trajectory in which
NO migrates between Xe2 and Xe4, whereas the broad and
structured green spectrum corresponds to a trajectory in
which the NO molecule migrates between Xe5 and Xe1,
and the entrance of channel I. Finally, the blue spectrum in
Fig. 10 b arises from a trajectory with the NO molecule in
Xe2. This information alone is not sufficient to assign partic-
ular spectral features to specific pockets sampled. To this
end, Fig. 10 c shows the averaged NO spectra when the
ligand movement is restricted to a given ligand docking
site. Such docking-site specific spectra provide a means for
a spectroscopic identification of ligand docking sites in
a protein. To achieve this, we collected the time series of
the dipole moments of NO from those parts of trajectories
where the ligand was localized in a given docking site
from which pocket-specific spectra were obtained. By aver-
aging over all such pocket-specific spectra from different
trajectories, we obtained averaged infrared spectrum of NO
ligand in particular docking sites. Since the ligand was not
found in the Xe3 and the Xe4 for a sufficiently long time
to calculate meaningful pocket-specific infrared spectra, the
analysis is only carried out for Xe1, Xe2, Xe5, and the prox-
imal docking site (see Fig. 10 c). By combining the informa-
tion from Fig. 10, b and c, the following assignments are
proposed: for NO in the Xe1 pocket, an infrared absorption
occurs at 1837.5 cm1 (i.e., unshifted with respect to free
NO), whereas the infrared absorption of the ligand in the
Xe5 pocket leads to signals at 1835 and 1841 cm1. The
ligand in Xe2 pocket shows three distinct absorption maxima
located at 1834, 1839, and 1842 cm1. The ligand in Xe3 or
Xe4 pocket shows red-shifted absorption (at <1834 cm1).
Finally, for the NOmolecule in the PDS, a blue-shifted broad
infrared peak at 1847 cm1 is found. In conclusion, the
infrared spectrum for unbound NO inside truncated hemo-
globin is expected to exhibit a relatively broad (z20 cm1)
spectrum with largely unresolved bands centered around the
absorption of free NO. For a spectroscopic characterization
of the ligand docking sites, however, site-specific infrared
spectra need to be recorded. This may also include investiga-
tion of suitably mutated proteins to block particular ligand
migration pathways.
TABLE 3 Position, intensity, and full width at half-maximum
(FWHM) of the Gaussian functions describing the proﬁle of the
averaged infrared spectrum of NO in trHbN (shown in Fig. 10 a)
Frequency (cm1) Intensity (%) FWHM
1834.3 45.5 1.97
1835.8 75.5 2.05
1837.5 100.0 3.14
1838.9 90.0 1.88
1840.6 92.3 2.88
1842.0 52.0 3.16Biophysical Journal 96(6) 2105–2118DISCUSSION AND CONCLUSIONS
By using the ligand as a probe, the present simulations have
characterized the internal structure of trHbN including active
site conformation, ligand migration pathways, ligand dock-
ing sites, and solvent-accessible regions. The connectivity
network given in Fig. 5 shows the possible transition path-
ways of the ligand within the protein matrix. The tunnel
system of trHbN plays an important role in determining
and controlling ligand entrance, migration, and rebinding.
The ligand is also seen to follow migration pathways besides
the tunnel, for example, migration from Xe1 and Xe3 pocket
via IS1 (see Fig. 5). In addition to the five Xe pockets found
in the crystallographic study of Milani et al. (12), the present
simulations find another ligand docking site in the proximal
side of the heme group in trHbN. The simulations reveal four
different regions of the protein from which the ligand can
escape the protein matrix to the bulk water. Two of these
pathways are the openings of channel I and II, surrounded
by apolar residues. The other two exit channels fall outside
the tunnel of the protein, accessible from the Xe2 and Xe5
pockets. While the exit pathway close to the Xe5 pocket
lies between helices E and F (surrounded by Pro71, Tyr72,
Phe62, Ala65, and Pro121 residues), the exit path close to
the Xe2 pocket is situated between the helices C and F (sur-
rounded by Phe46, Thr49, Met51, and Leu54). Both of these
extratunnelar exit paths are surrounded by at least one polar
residue, e.g., Thr, Pro, or Tyr. The exit channels surrounded
by polar residues are expected to be the preferred escape
channel for charged or highly polar ligands. Recently, a study
involving the release of NO3
 (the product of NO detoxifica-
tion) from the heme distal side to solvent finds that the polar
nitrate anion does not escape the protein via the well-charac-
terized apolar tunnels. Instead, the anion prefers a path
close to the Met51 and Thr49 residues in between helices C
and F (54).
The above discussion opens the possibility for competing
ligand-migration pathways operating in the protein matrix. A
nonpolar ligand, such as O2, prefers protein channels delin-
eated by apolar residues. On the contrary, a highly polar
ligand, such as the nitrate anion (NO3
), follows exit path-
ways surrounded by polar residues. The three-point fluctu-
ating charge model, employed in this work for NO, correctly
describes the strong quadrupole moment of the ligand.
Therefore, NO represents an intermediate case, where the
ligand is neither apolar nor highly polar. In such a case,
a competition between polar and nonpolar pathways is
possible, as is seen in this work (see Fig. 5).
Other recent studies exploring the interior of oxy-trHbN
were carried out with a grid-based MD method for fast and
unsupervised exploration of protein channels (55). In this
method, a precomputed grid of forces for protein conforma-
tions interact with the rigid probe (ligand). Although such an
approach is computationally efficient, it ignores the influence
of the ligand on the protein dynamics, which, in the present
NO Migration in Truncated Hemoglobin 2115work, is found to be important. Consequently, this study,
although it reports the presence of the exit pathway between
E and F helices, failed in locating the proximal docking site,
the intermediate site (IS1) between Xe1 and Xe3 pocket, and
the nonpolar exit pathway (between C and F helices), shown
to exist in the present work. All experimentally and computa-
tionally characterized pathways are found from a single
computational model in the present study, which is not the
case for previous simulations (28,54,55). The additional exit
channels are expected to be important for removing the prod-
ucts of NO detoxification reaction from the protein matrix.
Although our simulations are not sufficiently long to capture
the reentrance of the NO ligand from bulk to protein, by
observing four exit routes of the ligand, we anticipate that
the ligand can also enter the proteinmatrix via these pathways.
This can be verified by running long simulations with ligand
outside the protein matrix. The increased number of access
routes of the ligand should also increase the probability of
capturing nitric oxide for efficient detoxification.
Most likely, the novel observations of the proximal dock-
ing site as well as the exit channels, besides the tunnel open-
ings, are consequences of using an accurate electrostatic
model for the ligand. The Xe pockets and tunnel branches
observed from crystallographic studies suggest possible
ligand migration sites within and through the protein (56).
However, other and additional sites might be found from
atomistic simulations. The interactions between protein resi-
dues and the ligand mutually influence their dynamics and
may open additional localization sites and migration path-
ways. This has been previously shown for myoglobins
(35,57), and this study is an additional example. In this
context, it should be noted that simulations, in which the
ligand location is determined implicitly from the classical
molecular interaction potential (as in (27,28,52,55)), are
liable to failure in capturing the novel phenomena that arise
solely due to explicit interaction of the ligand with the fluc-
tuating protein.
In this work, the presence, energetics, and dynamics of the
active-site hydrogen-bonding network has been character-
ized explicitly. The resonance Raman spectrum of the oxy-
trHbN shows the Fe-O2 stretching mode at 562 cm
1
(17,18). Upon mutation of the Tyr33 to Leu33, this peak
shifted to 540 cm1, which is the Fe-O2 stretching frequency
observed in most other hemoglobins and myoglobins
(17,18). One possible reason for this observation is the pres-
ence of an H-bonding between Tyr33 and the bound O2
ligand. Furthermore, a red shift of the Fe-O2 stretching
frequency was seen upon Gln58Val mutation, indicating an
H-bond between the bound O2 and the Gln
58 residue
(17,18). Finally, the kinetic and equilibrium constants for
the reaction of ferrous HbN with O2 compared to those of
other proteins reveal that the O2 binding is twofold faster
in trHbN compared to sperm whale Mb, whereas O2 dissoci-
ation is two-orders-of-magnitude slower in trHbN. This is
because of the presence of a tunnel in the trHbN for a fasterligand diffusion to the heme active site and the presence of
a ligand-stabilizing residue (Tyr33) restricting ligand dissoci-
ation (15). The spectroscopic and kinetic studies thus suggest
the presence of an H-bonding network in the heme active
site. Previously, the existence of such a network has been
indirectly characterized through Tyr33Phe and Gln58Ala
mutational studies (28).
The present simulations show the presence of a dynamic
H-bonding network between the bound O2 ligand and
Tyr33 and Gln58 residues. From detailed analysis of the
residue movements, it is concluded that the phenolic O of
Tyr33 plays the role of both H-bond donor and acceptor
with the amide N of Gln58. Additionally, the phenolic O of
Tyr33 also participates as an H-bond donor to the amide O
of Gln58. This is in contrast to previous results (28) where,
from one 50-ns trajectory for oxy-trHbN, it was found that
Tyr33 acts exclusively as H-bond acceptor of the amide H
of Gln58 and as H-bond donor to bound O2. On the contrary,
our simulations suggest that the O2 ligand acts as H-bond
acceptor of both the phenolic H of Tyr33 as well as the amide
H of Gln58, and the H-bond between Tyr33 and O2 is
dynamic in nature. Three different conformations arising
from the mutual H-bonds between these moieties have
been identified (see Fig. 8 a) and energetic estimations of
the involved H-bonds have been provided (Fig. 8 b). While
the breaking of H-bond between O2 and Tyr
33 pertains
a barrier of 1.2 kcal/mol, the barriers involving the breaking
of H-bonds between Tyr33 and amide N and amide O of
Gln58 amounts to 1 kcal/mol and 2 kcal/mol, respectively.
The H-bonds among these moieties are frequently formed
and broken during simulations. The small energy barriers
indicate that the H-bonds in the heme active site are not
energy-demanding. The dynamic H-bonds involving small
energy requirements support the ligand chemistry that takes
place in the heme active site. Since the stability and mobility
of the intermediates and the products of the NO detoxifica-
tion process depend on the surrounding residues, the low
energy barriers are desirable for accommodation of different
reactive conformations that may play a role in the detoxifica-
tion reaction.
The Phe62 residue situated in the helix E of the trHbN lies
in a strategic position to control the ligand migration between
Xe5 and Xe1 pockets along channel I. From crystallographic
studies it is known that Phe62 adopts two conformations,
differing by a rotation around the Ca-Cb bond (11,12).
This aspect has been further studied by MD simulations
(27,28). By comparing the energy barriers associated with
ligand migration along the two channels, a dual path mech-
anism has been postulated, stating that O2 enters the deoxy-
trHbN from channel II, while NO enters the oxy-trHbN from
channel I (27,28). The present simulations substantiate this
observation with additional facts such as energy barrier
between the two conformations and direct observation of
the role of the Phe62 in ligand migration. We have estimated
the energy barrier for closed-state-to-open-state transition asBiophysical Journal 96(6) 2105–2118
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mol. Owing to the larger barrier, open-to-closed transition is
less frequent than the opposite. Our simulations revealed that
the open state of the Phe62 residue is prevalent in the case of
oxy-trHbN. It has been found that ligand migration between
pockets Xe1 and Xe5 along the channel I is correlated to
a conformational change of the Phe62 residue. The role of
Phe62 in trHbN as a gate controlling the ligand migration
along channel I is reminiscent of His64 in myoglobin, where
no permanent channel exists in the molecular structure of the
protein that connects the active site to the outside, but an
outward movement of the His64 imidazole side chain may
transiently open a pathway through which ligands may enter
or exit the distal heme cavity (58–61).
Using an anharmonic potential for the bond-stretching and
accurate electrostatic interactions including higher multipole
moments, for several diatomic ligands (such as CO, CN,
and NO) in myoglobin, it has been shown that the experi-
mentally observed splittings of the ligand absorption spec-
trum can be understood from MD simulations (51,53,
62–64). The averaged infrared spectra of NO, calculated in
this work (Fig. 10 a), is broad and extends over a spectral
window of 20 cm1 with a central intense peak at
1837.5 cm1. The averaged spectrum is broad with tails at
both sides of the maximum and exhibits several splittings;
these are typically 1.5–2 cm1. The considerable width of
the spectrum is in qualitative agreement with the experi-
mental infrared spectrum of NO in myoglobin (39,42), where
both blue and red shifts of the central intense peak are
observed. Similar to this spectra (see Fig. 10 a), the experi-
mental spectra of dissociated NO in myoglobin (39,42) are
broad and structured with peaks separated by a few wave
numbers. As for photodissociated CO in myoglobin, these
peaks most likely correspond to conformational substates
which, however, have not yet been unambiguously assigned.
In addition to the averaged infrared spectra of NO, the
individual spectra arising from trajectories, where ligand
samples different regions of protein, are also analyzed. In
recent years with the development of experimental tech-
niques, it is now possible to record infrared spectra of ligands
in specific ligand docking sites and spectroscopically charac-
terize the docking sites of the protein (65,66). This has also
been achieved in this computational work where pocket-
specific NO infrared spectra have been calculated. By
comparing the spectra shown in Fig. 10, a–c, the following
attempt to correlate structure and spectroscopy is made:
The central part of the averaged spectrum originates from
NO in Xe1, Xe2, and Xe5, which are buried inside the
protein and close to the heme active site. The peaks toward
the red side of the averaged spectrum are primarily due to
the ligand in Xe3, Xe4, and the opening of channel I. These
positions are away from the heme active site and close to the
surrounding bulk solvent, which gives rise to the red-shifted
peaks. On the other hand, the blue-shifted tail of the averaged
infrared spectrum is primarily due to the ligand in the prox-
Biophysical Journal 96(6) 2105–2118imal pocket, which consists of hydrophobic residues such
as Ile119, Phe91, His81, Val124, Val126, Ala123, Met77, and
Asp125. The polar side chain of Asp125 lies close to the
surrounding solvent molecules and away from the proximal
docking site, thus keeping the proximal docking site hydro-
phobic. The contribution of the Xe3, Xe4, and the proximal
docking sites to the overall spectrum is expected to be rather
minimal, whereas the overall spectrum is expected to be
dominated by the ligand located in Xe1, Xe2, and Xe5.
In summary, we have studied nitric oxide migration in the
trHbN of M. tuberculosis via molecular-dynamics simula-
tion, by using a fluctuating three-point charge model and
a Morse potential for the NO molecule. By analyzing the
ligand probability density, we have characterized the primary
ligand docking sites in the protein matrix. In addition to the
five Xe pockets found in the crystallographic study of Milani
et al. (12), our simulations find another ligand docking site
on the proximal side of the heme group in trHbN. By
studying the ligand dynamics, a connectivity network could
be determined that describes transition pathways of the
ligand in the protein matrix including novel migration path-
ways and exit channels. A structural and energetic account of
dynamic H-bonding network (among Tyr33, Gln58, and
bound O2) operating in the heme active site has been found
and characterized and the pivotal role of Phe62 in ligand
migration has been confirmed. Finally, the simulations allow
prediction of the (site-specific) infrared spectra of NO in
trHbN, which as yet have not been observed experimentally.
The different bands of the infrared spectrum have been as-
signed through comparison with pocket-specific infrared
spectra of NO ligand and it will be interesting to compare
these findings with experiments.
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